Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Encision Signs Master Services Agreement With Vicarious Surgical Inc.
Morgan Stanley Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $6.5
Express News | Piper Sandler Maintains Neutral on Vicarious Surgical, Adjusts Price Target To $12 From $30 (1-for-30 Reverse Stock Split)
Vicarious Surgical Analyst Ratings
Vicarious Surgical | 10-Q: Q2 2024 Earnings Report
Earnings Call: Vicarious Surgical Q2 Results, Partnerships, and Outlook
TD Cowen Maintains Vicarious Surgical(RBOT.US) With Buy Rating, Maintains Target Price $10
Piper Sandler Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $12
Piper Sandler Sticks to Their Hold Rating for Vicarious Surgical (RBOT)
Express News | Vicarious Surgical Inc : TD Cowen Adjusts Target Price to $10 From $1.50 to Reflect 1-for-30 Reverse Stock Split
Vicarious Surgical's Progress and Upcoming Milestones Merit a Buy Rating
Earnings Call Summary | Vicarious Surgical(RBOT.US) Q2 2024 Earnings Conference
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Express News | Vicarious Surgical Reiterates Expected FY24 Cash Burn Of ~$50M
Express News | Vicarious Surgical Inc: Q2 Adj Shr Loss $2.86
Express News | Vicarious Surgical Inc - Reiterates Expected Full Year 2024 Cash Burn of Approximately $50 Mln
Express News | Vicarious Surgical Q2 2024 Adj. EPS $(2.86) Misses $(2.77) Estimate
Vicarious Surgical 2Q Loss/Shr $2.59 >RBOT
Express News | Vicarious Surgical Reports Second Quarter 2024 Financial Results